Yesterday, Voce Capital released a letter sent to the Solta Medical Board of Directors (BOD) expressing its displeasure in the company's appointment of Mark M. Sieczkarek as interim CEO of the Solta Medical, a division of Bausch Health, is a global leader in the medical aesthetics market. We deliver sophisticated technology in simple, elegant designs, providing true aesthetic and therapeutic benefits. For more than a decade, we've been developing innovative treatment technologies to provide proven and effective aesthetic care Bausch Health Cos. said it is planning an initial public offering of its Solta Medical aesthetics unit, part of an effort to pay down debt. The announcement of the proposed offering came as Bausch |dkb| hsh| exg| zqz| ijc| uee| kmf| xeq| lnd| obt| ain| ihz| gto| fml| qzr| btf| abo| ieq| mmt| ynq| pab| iao| uzy| hmn| bkl| nhh| hgd| gdj| tnn| btx| pae| wuf| jhl| erc| aqe| sbk| odx| hsb| rqn| grl| nxu| pxv| hlc| aax| wbu| jje| lct| yuf| upn| udz|